Luke joined Summit in 2017 and focuses primarily on the healthcare & life sciences sector in Europe. His investment and board experience includes RadioOnkologieNetzwerk (acquired by Medipass) and Viroclinics Biosciences (acquired by Cerba Healthcare).

Prior to Summit, Luke served as Vice President in the Mergers & Acquisitions division of Jefferies.

Luke holds an MA in applied economics, with honors, from the University of St. Andrews.